Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?

K. E. Earp (Lead / Corresponding author), B. W. Hancock, D. Short, R. A. Harvey, R. A. Fisher, D. Drew, N. Sarwar, J. A. Tidy, M. C. Winter, P. Chien, M. J. Seckl

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)

    Fingerprint

    Dive into the research topics of 'Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry